Description

6-(2,3-Dihydro-1,4-benzodioxin-2-yl)-3-(3-fluorophenyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole is a high-purity, advanced pharmaceutical intermediate and research chemical with the CAS number 724435-92-1. This heterocyclic compound is valued for its complex molecular architecture, which serves as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly in areas requiring sophisticated nitrogen and sulfur-containing heterocycles.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, anti-inflammatory, or anti-infective pathways.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its fused triazolo-thiadiazole core for biological activity.
• Material Science: Investigated as a potential component in the creation of advanced organic electronic materials due to its conjugated system.
• Biochemical Research: Serves as a tool compound or a scaffold in medicinal chemistry for structure-activity relationship (SAR) studies.
• Organic Synthesis: Employed by synthetic chemists as a complex, multifunctional building block for constructing diverse heterocyclic libraries.

Basic Information

Product Name	6-(2,3-Dihydro-1,4-benzodioxin-2-yl)-3-(3-fluorophenyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
CAS No.	724435-92-1
Molecular Formula	C19H13FN4O2S
Molecular Weight	380.40 g/mol
Synonyms	6-(2,3-Dihydro-1,4-benzodioxin-2-yl)-3-(3-fluorophenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole; 3-(3-Fluorophenyl)-6-(1,4-benzodioxan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole; 724435-92-1; Triazolothiadiazole derivative; Benzodioxinyl triazolothiadiazole; Fluorophenyl triazolothiadiazole; Fused heterocyclic compound
EINECS	Contact for details

Quality Control

Our production of 6-(2,3-Dihydro-1,4-benzodioxin-2-yl)-3-(3-fluorophenyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. All materials are characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment to support your research and development or cGMP manufacturing requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container sealed to protect this light-sensitive compound from degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any individual impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.